Kansai - I tend to agree with you, which is all the more reason to lock down the IP and protect the product. I would hope that after leadership receives a couple fat orders, they will spend the money on IP protection as they also build their brand. I know locking down anything in China is tough, but we need to try. If so, Scrips will be able to snatch much more of that growing $32B drug market.

Let's roll!

BSAV